TrialWorld journal of experimental medicine2024

Dapagliflozin as an oral antihyperglycemic agent in the management of diabetes mellitus in patients with liver cirrhosis.

Zeinab Seif El-Din et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.